
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma
Zhi-Zhang Yang, Hyo Jin Kim, Hongyan Wu, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Zhi-Zhang Yang, Hyo Jin Kim, Hongyan Wu, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Cellular and molecular determinants mediating the dysregulated germinal center immune dynamics in systemic lupus erythematosus
Spiros Georgakis, Kalliopi Ioannidou, Bernat Bramon Mora, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Spiros Georgakis, Kalliopi Ioannidou, Bernat Bramon Mora, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment
Ali Golestan, Mohammadrasul Zareinejad, Amin Ramezani
Biomarkers in Medicine (2025), pp. 1-16
Closed Access
Ali Golestan, Mohammadrasul Zareinejad, Amin Ramezani
Biomarkers in Medicine (2025), pp. 1-16
Closed Access
T cell aging and exhaustion: Mechanisms and clinical implications
Weiqi Zhang, Dejun Kong, Xiaohan Zhang, et al.
Clinical Immunology (2025) Vol. 275, pp. 110486-110486
Closed Access
Weiqi Zhang, Dejun Kong, Xiaohan Zhang, et al.
Clinical Immunology (2025) Vol. 275, pp. 110486-110486
Closed Access
Advances in Personalized Treatment and Prognostic Factors of Follicular Lymphoma
Shijia Cheng, Yanyan Liu
Current Treatment Options in Oncology (2025)
Closed Access
Shijia Cheng, Yanyan Liu
Current Treatment Options in Oncology (2025)
Closed Access
Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review
Marie Beck Enemark, Jonas Klejs Hemmingsen, Maria Fuglsang Jensen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11179-11179
Open Access | Times Cited: 2
Marie Beck Enemark, Jonas Klejs Hemmingsen, Maria Fuglsang Jensen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11179-11179
Open Access | Times Cited: 2
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203
Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, et al.
Hematological Oncology (2024) Vol. 42, Iss. 3
Open Access | Times Cited: 1
Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, et al.
Hematological Oncology (2024) Vol. 42, Iss. 3
Open Access | Times Cited: 1
Quantification and profiling of early and late differentiation stage T-cells in mantle cell lymphoma reveals immunotherapeutic targets in subsets of patients
Lavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Lavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients
Cong Li, Na Guo, Shuiyun Han, et al.
Cancer Medicine (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 1
Cong Li, Na Guo, Shuiyun Han, et al.
Cancer Medicine (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 1
Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients
Lavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2289-2289
Open Access
Lavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2289-2289
Open Access